# Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR

Source: https://welltoldgrants.com/grants/cdc-rfa-gh21-2157-strengthening-the-provision-of-accessible-and-quality/  
Official notice: https://www.grants.gov/search-results-detail/331852

> Centers for Disease Control - CGH offered grants to the applicants described in the notice. It expected to make one award. Applications closed on May 14, 2021.

| Field | Value |
|---|---|
| Opportunity number | CDC-RFA-GH21-2157 |
| Agency | Centers for Disease Control - CGH |
| Status | Forecast |
| Deadline | May 14, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.067 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Eligible applicants that can apply for this NOFO are: Namibia Institute of Pathology (NIP)

## What the grant funds

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,500,000 for Year 1, subject to the availability of funds. Over the next five years, diagnostic network optimization (DNO) within the laboratory system will be the primary overarching activity since it pinpoints deficiencies and strengthens the identified gaps remaining to reach sustained epidemic control of HIV and TB in Namibia, as well as responds to outbreak needs as they occur. Broadly, the activities under this NOFO will include: 1) the establishment of a national transport system using the Namibia Institute of Pathology (NIP) system as a base, 2) workflow analyses to assess testing needs based on number of patients on antiretroviral therapy (ART), 3) assessment of instrument utilization, and 4) establishment of a national unique patient identifier. These activities will enable the country to better track patients from one viral load (VL) test to the next to ensure suppression rates are accurate for all patients on ART, enhance and expand infant diagnosis to greater than the current 80% coverage, and ensure that all HIV patients that are dually infected with TB are diagnosed and treated.

## Questions people ask

### Is CDC-RFA-GH21-2157 still open?

No. It closed on May 14, 2021.

### Who can apply for Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR?

Centers for Disease Control - CGH accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR?

Closed May 14, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has won Global AIDS grants before?

The largest recipients over five fiscal years were The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric AIDS Foundation, Management and Development for Health. The program made 521 awards worth $7.6 billion in that time.